Anteris Technologies Global Corp. — M&A Activity 2022

Feb 14, 2022

ASX ANNOUNCEMENT

15 February 2022

AVR MERGER PROPOSAL UPDATE

Brisbane, Australia and Minneapolis, USA . Anteris Technologies Ltd (ASX: AVR) (Anteris or the Company) declines the proposal to merge with NASDAQ-listed special purpose acquisition company Medicus Sciences Acquisition Corp (MSAC).

Despite some advantages, such as relatively expeditious access to US capital markets, the Company’s Board concluded the timing of the proposal was not in shareholders nor the Company’s best interest at this point.

The Company appreciates its shareholders’ support and remains focused on achieving its objectives throughout 2022.

“MSAC’s proposal underscores the high interest in the Company’s game-changing DurAVR[TM] THV potential, not only among US TAVR interventionist fraternity but, also, in key sections of US capital markets,” Anteris CEO Wayne Paterson said.

ENDS

About Anteris Technologies Ltd (ASX: AVR)

Anteris Technologies Ltd is a structural heart company that delivers clinically superior and durable solutions through better science and better design.

Its focus is developing next-generation technologies that help healthcare professionals reproduce consistent life-changing outcomes for patients.

Anteris’ DurAVR[™] 3D single-piece aortic heart valve replacement addresses the needs of tomorrow’s younger and more active aortic stenosis patients by delivering superior performance and durability through innovations designed to last the remainder of a patient’s lifetime.

The proven benefits of its patented ADAPT[®] tissue technology, paired with the unique design of our DurAVR[™] 3D single-piece aortic heart valve, have the potential to deliver a game-changing treatment to aortic stenosis patients worldwide and provide a much-needed solution to the challenges facing doctors today.

Authorisation and Additional information

This announcement was authorised by the Board of Directors.

Anteris Technologies Ltd Registered Office:

Toowong Tower, Suite 302, Level 3, 9 Sherwood Rd, Toowong, Queensland, 4066 Customer Service

T +61 1300 550 310 | F +61 1300 972 437 | E info.au@anteristech.com | W anteristech.com

==> picture [95 x 51] intentionally omitted <==

Brisbane ▪ Minneapolis ▪ Geneva ▪ Malaga

For more information:

Hannah Howlett WE Communications E: WE-AUAnterisTech@we-worldwide.com P: +61 4 5064 8064 www.anteristech.com Twitter: @AnterisTech Facebook: www.facebook.com/AnterisTech

LinkedIn: https://www.linkedin.com/company/anteristech

==> picture [95 x 52] intentionally omitted <==